|
|
|
11172
|
|
|
P.I.:
|
Richard Pezner, MD
|
(Cooperative Group)
|
|
Title:
|
ACOSOG Z4099/RTOG 1021: A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) versus Stereotactic Body Radiation Therapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)
|
| | |
|
|
11161
|
|
|
P.I.:
|
Kimlin Ashing-Giwa, PhD
|
(NCI Approved External Peer Review)
|
|
Title:
|
Administrative Supplement to Expand NCI-Supported Community Outreach Capacity through Community Health Educators (CHEs) of the National Outreach Network
|
| | |
|
|
11156
|
|
|
P.I.:
|
Robert Chen, MD
|
(Institutional)
|
|
Title:
|
Acquisition of Peripheral Blood and/or Bone Marrow Aspirate from Patients with Chronic Lymphocytic Leukemia for Method Development of
Aptamers Based Delivery Method of RNAi
|
|
|
11144
|
|
|
P.I.:
|
Sumanta Pal, MD
|
(Institutional)
|
|
Title:
|
GU09-145, Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus for Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
|
| | |
|
|
11138
|
|
|
P.I.:
|
Robert Morgan, MD
|
(Industrial)
|
|
Title:
|
An Open Label, Multi-Center, IRESSA Clinical Access Program of Gefitinib 250 mg (IRESSA) for the Continued Treatment of Patients in the United States who are Currently Benefiting or who have Benefited from Gefitinib Treatment
|
|